Mitoxantrone and cyclophosphamide combination chemotherapy for the treatment of various canine malignancies

Journal of the American Animal Hospital Association

Volumn 35, Issue 3, 1999, Pages 236-239

  Henry, Carolyn J ^a,c   Buss, Michael S ^b   Potter, Kathleen A ^b   Wardrop, K Jane ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c Vet Int Med Specialists Kansas C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CEFAZOLIN; CYCLOPHOSPHAMIDE; ENROFLOXACIN; FUROSEMIDE; MITOXANTRONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SALAZOSULFAPYRIDINE; SODIUM CHLORIDE; TRIMETHOPRIM;

ADENOCARCINOMA; ANGIOSARCOMA; ARTICLE; BONE MARROW SUPPRESSION; CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CLINICAL PROTOCOL; DERMATOFIBROMA; DOG; FIBROSARCOMA; LETHARGY; LYMPHOMA; MYOSARCOMA; NEUTROPHIL; NONHUMAN; SARCOMA; SQUAMOUS CELL CARCINOMA; SYNOVIAL SARCOMA;

EID: 0032906856     PISSN: 05872871     EISSN: None     Source Type: Journal    
DOI: 10.5326/15473317-35-3-236     Document Type: Article

References (10)

1. Riggs CE. Antitumor antibiotics and related compounds. In: Perry MC, ed. The chemotherapy sourcebook. Baltimore: Williams & Wilkins, 1992: 318-58.
2. Ogilvie GK, Obradovich JE, Elmslie RE, et al. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc 1991;198: 1618-21.
3. Ogilvie GK Obradovich JE, Elmslie RE, et al. Toxicoses associated with administration of mitoxantrone to dogs with malignant tumors. J Am Vet Med Assoc 1991;198:1613-7.
4. Bezwoda WR, Hesdorffer C. The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancer. Cancer 1986;58:1621-4.
5. Mulder POM, Sleijfer DT, Willemse PHB, et al. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors. Cancer Res 1989;49:4654-8.
6. Bennet JM, Muss HB, Doroshow JH, et al. A randomized multicenter trial comparing nitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma. J Clin Oncol 1988;6:1611-20.
7. Leonard RCG, Cornbleet MA, Kaye SB, et al. Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast. J Clin Oncol 1987;5:1056-63.
8. Owen LN, ed. TNM classification of tumors in domestic animals. Geneva: World Heath Organization, 1980.
9. Goodman SA, McPherson J, Rossimeisel JA, et al. Recombinant human granulocyte colony stimulating factor decreases myelosuppression in normal dogs following repeated cycles of mitoxantrone and cyclophosphamide chemotherapy without development of neutralizing antibodies. J Vet Int Med, in press.
10. Henry CJ, Buss MS, Lothrop C. Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part I: Oncology. Compendium 1998;20:728-35.